BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 4, 2020
View Archived Issues
Cutting off AML's metabolic escape route
Read More
Challenges for mutation correction in human embryos
Read More
FDA approves Bronchitol inhalation powder for patients with cystic fibrosis
Read More
Innovation Pharmaceuticals receives pre-IND response for brilacidin trial in COVID-19
Read More
FDA clears IND application for phase I/II study of EG-70 in NMIBC
Read More
Adakveo approved in Europe to prevent VOCs in patients with sickle cell disease
Read More
Concert initiates phase III THRIVE-AA1 study of CTP-543 for alopecia areata
Read More
AT-752 improves survival in mouse model of dengue infection
Read More
Nurix Therapeutics patents CBLB inhibitors
Read More
Plexxikon discloses KAT3B and CREBBP inhibitors
Read More
Bristol Myers Squibb identifies new Gal-3 inhibitors
Read More
Nuvation Bio describes new Wee1 inhibitors
Read More
Tenaya Therapeutics presents AAV5 compositions
Read More
Serine deprivation spurs selective translation in pancreatic cancer
Read More
JCR begins global phase I/II trial of JR-171 for MPS I
Read More
Combination of donepezil and quetiapine or PDE10A inhibitors provides synergic anti-BuChE activity
Read More
Phase III results for molidustat in patients with renal anemia undergoing dialysis
Read More
LV20.19, a bispecific CAR T-cell therapy for RR B-cell malignancies: results from phase I trial
Read More
Biodistribution, dosimetry and preclinical efficacy data presented for [177Lu]rhPSMA-7.3
Read More
New PROTACs synthesized by C4 Therapeutics
Read More
BiomX begins first-in-human study of BX-002 phage therapy for IBD
Read More
Phase II/III study of voclosporin ophthalmic solution in dry eye does not meet primary endpoint
Read More
IO Biotech announces new phase II trial of cancer immunotherapies in head & neck cancer
Read More
Aligos begins first-in-human trial of ALG-000184 for chronic hepatitis B
Read More
HT-005 reduces skin plaque severity in cutaneous lupus erythematosus mouse model
Read More